Manufacturing & Supply Chain

Pfizer is to manufacture a Covid-19 vaccine drug substance at its Grange Castle facility in Dublin. Pfizer plans to invest some $40 million in the expansion of the Grange Castle site to allow for the extra production that will be part of the global Pfizer-BioNTech COVID-19 Vaccine supply chain network, contributing to the worldwide supply of the vaccine. 75 new roles are to be created as a result.

Tanaiste and Minister for Business, Enterprise & Innovation, Leo Varadkar said: “Ireland is globally recognised as a centre of excellence for the Life Sciences and this investment is a real vote of confidence in us and our capacity. With this announcement, we will have a central role to play in the Covid-19 response, helping to produce this life saving vaccine in Dublin, creating 75 new, highly skilled jobs. These vaccines have saved countless lives and I’m really happy Pfizer has chosen to produce components of them here.”

IDA Ireland CEO Martin Shanahan said: “It underlines the importance of the pharma sector in Ireland and demonstrates the capability of the biological sector here. This is most welcome news and a strong vote of confidence in the skills, expertise and capability to manufacture this mRNA drug substance here. Pfizer has played an important part to date in the delivery of vaccine to help in the fight against Covid-19 and it is great that the company’s efforts will now be assisted by the production of this mRNA drug substance from Ireland. The 75 jobs being created at the Grange Castle facility are also extremely welcome.”